Leukaemia Trial, Recruiting (NCT03711110)

Leukaemia Trial, Recruiting NCT03711110 Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León Condition: Leukaemia

Printed from Voxsanity (voxsanity.com.au) — NCT03711110 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Leukaemia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are over 65 years old
Your doctors expect you to live for more than 1 year
You have been diagnosed with one of the following cancers: colon cancer, breast cancer, lymphoma, chronic lymphocytic leukaemia, chronic myeloid leukaemia, or myeloma
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

You are already taking part in another clinical trial that would conflict with the schedule or procedures of this trial (if it does not conflict, you may still be able to join — confirm with trial site)
You have previously received cancer treatments that are known to potentially cause heart damage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pedro L Sánchez, Ph. D., IBSAL-Instituto de Investigación Biomédica de Salamanca

Phone: 923 291100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03711110

Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Phase: Not Applicable

Status: Recruiting

Condition: Leukaemia

Trial contact: 923 291100

More information: https://clinicaltrials.gov/study/NCT03711110

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are over 65 years old
Your doctors expect you to live for more than 1 year
You have been diagnosed with one of the following cancers: colon cancer, breast cancer, lymphoma, chronic lymphocytic leukaemia, chronic myeloid leukaemia, or myeloma
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

You are already taking part in another clinical trial that would conflict with the schedule or procedures of this trial (if it does not conflict, you may still be able to join — confirm with trial site)
You have previously received cancer treatments that are known to potentially cause heart damage

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Registry

ClinicalTrials.gov

Start date

2 August 2019

Est. completion

2 August 2024

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

All-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov